Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gore

Showing results (701-710 of 833) with videos related to

Pageof 84
Sort By:
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial TrustF Balkwill, R C Bast, J Berek, et al.
The Canadian Journal of Cardiology|November 25, 2011
The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)Hani Amad, Andrew T Yan, Raymond T Yan, et al.
Circulation|May 1, 1990
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trialW J Rogers, D S Baim, J M Gore, et al.
Coronary Artery Disease|July 28, 2010
Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registryHoa L Nguyen, Robert J Goldberg, Joel M Gore, et al.
International Journal of Cardiology|April 28, 2015
Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromesNigel S Tan, Shaun G Goodman, Raymond T Yan, et al.
American Heart Journal|February 5, 2004
Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarctionRajendra H Mehta, Immad Sadiq, Robert J Goldberg, et al.
JAMA|June 24, 2000
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarctionC P Cannon, C M Gibson, C T Lambrew, et al.
Transplantation|March 1, 1990
Unrelated donor marrow transplantation between 1977 and 1987 at four centers in the United KingdomM R Howard, J M Hows, S M Gore, et al.
Revista Espanola De Cardiologia|May 2, 2009
In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary eventsJosé López-Sendón, Omar H Dabbous, Esteban López de Sá, et al.
Pageof 84

Showing results (701-710 of 833) with videos related to

Sort By:
Pageof 84
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial TrustF Balkwill, R C Bast, J Berek, et al.
The Canadian Journal of Cardiology|November 25, 2011
The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)Hani Amad, Andrew T Yan, Raymond T Yan, et al.
Circulation|May 1, 1990
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trialW J Rogers, D S Baim, J M Gore, et al.
Coronary Artery Disease|July 28, 2010
Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registryHoa L Nguyen, Robert J Goldberg, Joel M Gore, et al.
International Journal of Cardiology|April 28, 2015
Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromesNigel S Tan, Shaun G Goodman, Raymond T Yan, et al.
American Heart Journal|February 5, 2004
Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarctionRajendra H Mehta, Immad Sadiq, Robert J Goldberg, et al.
JAMA|June 24, 2000
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarctionC P Cannon, C M Gibson, C T Lambrew, et al.
Transplantation|March 1, 1990
Unrelated donor marrow transplantation between 1977 and 1987 at four centers in the United KingdomM R Howard, J M Hows, S M Gore, et al.
Revista Espanola De Cardiologia|May 2, 2009
In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary eventsJosé López-Sendón, Omar H Dabbous, Esteban López de Sá, et al.
Pageof 84